Matt Bender

🚨 New study in Clinical Neurology and Neurosurgery on aneurysmal subarachnoid hemorrhage (aSAH) management 🩸 🧠 Anticipatory initiation of Intrathecal Nicardipine (ITN)—given before clinical or imaging evidence of delayed cerebral ischemia (DCI)—significantly reduces DCI parenchymal infarcts compared to controls (31.3% vs 55.2%). Key findings: 📉 Starting ITN prior to intra-arterial (IA) spasmolytics significantly lowers the need for serial IA treatments for recalcitrant vasospasm from 71.4% down to 23.1%. 🛡️ It is a safe intervention with no increased risk of EVD-related complications or meningitis. ⚠️ Timing is everything, because reactionary ITN given after DCI onset did not reduce the rate of additional infarcts or the need for serial IA treatments. Question: Does this article change your practice? #NeuroTwitter #NeuroCriticalCare #SubarachnoidHemorrhage #Vasospasm #NeuroSurgery sciencedirect.com/science/articl…

We are honored to welcome Matthew T. Bender, M.D., from @URNeurosurgery, as our Invited Visiting Professor! Join us as we host Dr. Bender for an insightful session sharing his expertise in neurosurgery and patient care. #VisitingProfessor #WakeForestNeurosurg

🧠 New narrative review: A proposed disease model for #IIH suggests altered brain fluid regulation, linked to obesity, may drive a cycle of fluid buildup, venous compression, & ⬆️intracranial pressure. Read the full article: …adachejournal.onlinelibrary.wiley.com/share/WHKRY8UU… @D_SchartzMD @mtbendermd

Excited to have presented my research looking at differences in thrombectomy times based on various social determinants at the regional #APSA conference in Rochester, with my colleagues presenting at #CNS! Thank you for the support from @visishs and @PennNSG over the past year!

Asymptomatic Hemorrhagic Transformation After Thrombectomy Is associated with substantially worse clinical outcomes neurology.org/doi/10.1212/CP…